Challenging the Reduction of Pharmaceutical and
Medical Device Marketing Costs to Achieve Universal Health Coverage
Decision-making support service that drives effective marketing while eliminating inefficiencies
Concept
InsighTCROSS® is a decision-support service developed to assist pharmaceutical and medical device companies in optimizing their sales and marketing activities. In recent years, marketing expenditures in the pharmaceutical industry have surpassed research and development (R&D) costs and continue to rise annually. Notably, approximately 30% of these marketing efforts are considered inefficient.
By leveraging data science, InsighTCROSS® visualizes physicians' subconscious behaviors, enabling the formulation of optimal marketing strategies. This approach transcends traditional methods reliant on intuition, facilitating evidence-based decision-making. Moreover, InsighTCROSS® evaluates marketing activities from the physicians' perspective, clearly distinguishing between effective and ineffective initiatives.
Through these efforts, InsighTCROSS® aims to reduce marketing costs, thereby contributing to the achievement of the United Nations' Sustainable Development Goal 3: "Good Health and Well-Being for All."
Stratifies your product from the customer's perspective, categorizing it by an individual customer.
Predicts the probability of individual customers for your product.
Matches customers who have a favorable view of your product.
Measures the return on investment (ROI) of your marketing campaigns.
Summarizes a vast amount of daily reports concisely.
About Team
Our consultants bring extensive expertise in pharmaceutical and
medical device marketing, supporting your strategy with proven results.
Satoru Hashimoto
Areas of Expertise
Product marketing (medical devices and pharmaceuticals), event planning, management, and data science
Affiliations and Academic Societies
The Japanese Association of Science and Technology Journalists
International Science Writers Association (ISWA)
Japan Society of Healthcare Management
Japan Society of Healthcare and Hospital Administration
Educational Background
Bachelor of Business Administration, Bellevue University (BS: cum laude)
MBA (cum laude), Graduate School of Management, Globis University
Doctoral Candidate, Graduate School of Strategic Management, Chuo University
Yoshihiro Motozawa
Areas of Expertise
General cardiology, healthcare marketing (medical devices and pharmaceuticals), digital marketing (user thinking and behaviour analysis), healthcare business management and business strategy (problem identification and planning)
Affiliated organization/Academic society
Japanese Society of Internal Medicine
Japanese Circulation Society Cardiovascular Specialist
Education
Graduated from the University of Tokyo Faculty of Medicine (M.D.)
Graduated from the University of Tokyo Graduate School of Medicine (PhD.)
Publications
- Hashimoto, S., Motozawa, Y., Mano, T. Selection criteria in the era of perfect competition for drug-eluting stents - a survey of interventional cardiologists in Japan: the selection-DES study. Expert Rev Med Devices. 2023 Jul-Dec; 20(12): 1235-1242. doi: 10.1080/17434440.2023.2277221. Epub 2023 Nov 24.
- Hashimoto, S., Motozawa, Y., Mano, T. Effect of the Japanese medical office system on job satisfaction, loyalty, engagement, and organizational commitment of medical practitioners: a survey of cardiologists in the acute care setting. BMC Health Serv Res. 2024 Jan 26; 24(1): 139. doi: 10.1186/s12913-023-10507-6.
- Hashimoto, S., Motozawa, Y., Mano, T. Effects of the Japanese medical office system on innovation creation among medical doctors: A survey of cardiologists in acute care settings. Int J Healthc Manag. 2024. doi: 10.1080/20479700.2024.2346880.
- Hashimoto, S., Motozawa, Y., Mano, T. Selection criteria for anticoagulants: survey of Japanese cardiologists based on their daily clinical practice: the Selection DOAC study. Curr Med Res Opin. 2024 Jul; 40(7): 1077-1082. doi: 10.1080/03007995.2024.2365999. Epub 2024 Jun 17.
- Hashimoto, S., Motozawa, Y., Mano, T. Selection Criteria in the Era of Perfect Competition for Drug-Eluting Stents in Association With Operator Volumes: An Operator-Volume Analysis of the Selection DES Study. Cardiol Res. 2024 Jun; 15(3): 189-197. doi: 10.14740/cr1651. Epub 2024 Jun 25.
- Hashimoto, S., Motozawa, Y., Mano, T. Digital marketing innovation: New business models for pharmaceutical and medical device product marketing. Digit Health. 2024 Aug 30:10:20552076241279186. doi: 10.1177/20552076241279186. eCollection 2024 Jan-Dec.
FAQ
There are common questions and showcase how
InsighTCROSS delivers measurable impact.
The base data comes directly from our clients. This ensures the analysis is tailored and highly relevant to their unique environment.
We use hospital or physician-level sales records, target customer attributes, and sales and marketing activity logs.
Through our proprietary software. Clients can also export reports as PDFs or print them on demand.
Using statistical methodologies customized to the nature and quality of the client's data.
Based on physician attributes, professional affiliations, sales history, and marketing engagement.
We conduct targeted surveys, designed in collaboration with experienced data scientists, to fill the gaps.
We match physician profiles and sales data to identify those most likely to prescribe your product.
It depends on your data. High-quality input leads to highly precise and actionable results.
We calculate ROI based on year-over-year sales increases attributed to campaign activity.
Not in the basic ROI model, but our Prescription Probability Enhancement feature allows micro-level analysis of sales and campaign effects combined.
Yes. Any industry with customer-level data and sales/marketing records can benefit from our platform.
No. We’ve applied it successfully in other therapeutic areas, including rare diseases.
Not necessarily. Accuracy depends more on data quality than on the specific medical field.
No. Source data is essential for all analyses.
While we can’t comment on all competitors, we’re happy to compare if you provide a specific example.
Our learning algorithms improve accuracy over time and visualize data usage to enhance input quality.
Yes. We’ll assess your data first. Most inconsistencies can be resolved through statistical processing.
Absolutely. We tailor features and interfaces to your specific operational and analytical needs.
A monthly subscription fee applies, based on your data volume and target physician count. Please contact us for a detailed estimate.
We use secure, high-reliability servers and are equipped to respond to new threats, including unknown viruses.
Yes. InsighTCROSS has been implemented by top pharmaceutical and medical device firms, with results shared via articles and demo videos on our website.
Inquiry
Ready to See the Impact of Smarter Data?
Contact TCROSS today to learn how InsighTCROSS
can turn your raw data into strategic intelligence.